Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy

INTRODUCTION: Approximately, 20% of patients with pancreatic ductal adenocarcinoma have resectable disease at diagnosis. Given improvements in locoregional and systemic therapies, some patients with borderline resectable pancreatic cancer (BRPC) can now undergo successful resection. The outcomes of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Gastrointest Surg
Hauptverfasser: Javed, Ammar A., Wright, Michael J., Siddique, Ayat, Blair, Alex B., Ding, Ding, Burkhart, Richard A., Makary, Martin, Cameron, John L., Narang, Amol, Herman, Joseph, Zheng, Lei, Laheru, Daniel, Weiss, Matthew J., Wolfgang, Christopher, He, Jin
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329638/
https://ncbi.nlm.nih.gov/pubmed/30242644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11605-018-3966-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge